Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -9.501% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) CC(C)CNC(=S)NC(=O)c1csc([N+](=O)[O-])c1
b) O=C(c1cc2sccc2n1Cc1ccc(F)cc1)N1CCN(c2nc3ccccc3s2)CC1
c) CSc1ncccc1C(=O)N(C)CC(=O)Nc1ccc(Cl)cc1
Answer: c. CSc1ncccc1C(=O)N(C)CC(=O)Nc1ccc(Cl)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSc1ncccc1C(=O)N(C)CC(=O)Nc1ccc(Cl)cc1
CSc1ncccc1C(=O)N(C)CC(=O)Nc1ccc(Cl)cc1
N-[2-(4-chloroanilino)-2-oxoethyl]-N-methyl-2-methylsulfanylpyridine-3-carboxamide